跳至主要内容
临床试验/IRCT201106101556N24
IRCT201106101556N24已完成2 期

Tropisetron on negative symptoms in patients with chronic schizophrenia: a double blind and placebo controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Inclusion Criteria: Age between 18-50,2-Diagnosis of Schizophrenia based on DSM IV 3-chronic Schizophrenia, 4- minimum Score of 20 on negative subscale of PANSS,5-stable on antipsychotic

排除标准

  • 1- Substance dependence,2- IQ <70,3-any other mental disorder on axis I, 4-Any serious medical or neurological problem ,5- receiving oral antipsychotic medications during the last week or receiving any depot antipsychotic medication during the last month,6- receiving ECT during the last 14 days

研究者

相似试验

进行中(未招募)
不适用
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks - REAL LIFE
EUCTR2005-003485-42-DEycomed GmbH2,000
进行中(未招募)
1 期
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeksRespuesta al tratamiento en pacientes con síntomas debidos a la enfermedad por reflujo gastroesofágico, con o sin esofagitis, tratados con 40 mg de pantoprazol sódico o.d. durante 8 semanas” - REAL LIFE
EUCTR2005-003485-42-ESALTANA Pharma AG2,000
进行中(未招募)
不适用
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks - REAL LIFEgastroesophageal reflux diseaseMedDRA version: 8.1Level: lltClassification code 10017885
EUCTR2005-003485-42-ATALTANA Pharma AG2,000
进行中(未招募)
1 期
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks - REAL LIFEgastroesophageal reflux diseaseMedDRA version: 8.1 Level: llt Classification code 10017885
EUCTR2005-003485-42-GBycomed GmbH2,000
进行中(未招募)
不适用
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks - REAL LIFEgastroesophageal reflux diseaseMedDRA version: 8.1Level: lltClassification code 10017885
EUCTR2005-003485-42-BEALTANA Pharma AG2,000